1027 related articles for article (PubMed ID: 18337202)
1. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
[TBL] [Abstract][Full Text] [Related]
2. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
Sheng ZF; Xu K; Ma YL; Liu JH; Dai RC; Zhang YH; Jiang YB; Liao EY
Osteoporos Int; 2009 Jan; 20(1):151-9. PubMed ID: 18496637
[TBL] [Abstract][Full Text] [Related]
3. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
4. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
5. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice.
Lloyd SA; Yuan YY; Kostenuik PJ; Ominsky MS; Lau AG; Morony S; Stolina M; Asuncion FJ; Bateman TA
Calcif Tissue Int; 2008 May; 82(5):361-72. PubMed ID: 18465074
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study on effect of osthole and genistein on peak bone mass in rats].
Cheng K; Ge BF; Zhen P; Chen KM; Ma XN; Zhou J; Song P; Ma HP
Zhongguo Gu Shang; 2014 Jul; 27(7):587-91. PubMed ID: 25338447
[TBL] [Abstract][Full Text] [Related]
7. Genistein and Silicon Synergistically Protects Against Ovariectomy-Induced Bone Loss Through Upregulating OPG/RANKL Ratio.
Chen C; Zheng H; Qi S
Biol Trace Elem Res; 2019 Apr; 188(2):441-450. PubMed ID: 30014283
[TBL] [Abstract][Full Text] [Related]
8. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
9. [Bone mass change and its possible mechanisms in murine knockout apolipoprotein E(ApoE-/-)].
Wang M; Li XP; Zhao LL; Liao EY; Luo XH
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2963-7. PubMed ID: 20137704
[TBL] [Abstract][Full Text] [Related]
10. Thyrotoxicosis Involves β2-Adrenoceptor Signaling to Negatively Affect Microarchitecture and Biomechanical Properties of the Femur.
Neofiti-Papi B; Albuquerque RP; Miranda-Rodrigues M; Gonçalves NJN; Jorgetti V; Brum PC; Ferreira JCB; Gouveia CHA
Thyroid; 2019 Aug; 29(8):1060-1072. PubMed ID: 31264512
[No Abstract] [Full Text] [Related]
11. Development of a low-dose anti-resorptive drug regimen reveals synergistic suppression of bone formation when coupled with disuse.
Lloyd SA; Travis ND; Lu T; Bateman TA
J Appl Physiol (1985); 2008 Mar; 104(3):729-38. PubMed ID: 18174391
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
13. [Comparison research with icariin and genistein by anti-inflammatory reaction and angiogenesis pathway to inhibit bone loss on ovariectomized rats].
Cheng K; Chen KM; Ge BF; Zhen P; Gao YH; Ma HP
Zhong Yao Cai; 2014 Apr; 37(4):627-31. PubMed ID: 25345138
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Effects of Genistein and Zinc on Bone Metabolism and the Femoral Metaphyseal Histomorphology in the Ovariectomized Rats.
Qi S
Biol Trace Elem Res; 2018 Jun; 183(2):288-295. PubMed ID: 28842860
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate treatment increases the size of the mandibular condyle and normalizes growth of the mandibular ramus in osteoprotegerin-deficient mice.
Kimura M; Miyazawa K; Tabuchi M; Maeda H; Kameyama Y; Goto S
Calcif Tissue Int; 2008 Feb; 82(2):137-47. PubMed ID: 18183447
[TBL] [Abstract][Full Text] [Related]
17. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation.
Li B; Yu S
Biol Pharm Bull; 2003 Jun; 26(6):780-6. PubMed ID: 12808286
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of 17beta-estradiol, raloxifene and genistein on bone 3D microarchitecture and volumetric bone mineral density in the ovariectomized mice.
Cano A; Dapía S; Noguera I; Pineda B; Hermenegildo C; del Val R; Caeiro JR; García-Pérez MA
Osteoporos Int; 2008 Jun; 19(6):793-800. PubMed ID: 17968609
[TBL] [Abstract][Full Text] [Related]
19. Cooperative effects of exercise training and genistein administration on bone mass in ovariectomized mice.
Wu J; Wang XX; Takasaki M; Ohta A; Higuchi M; Ishimi Y
J Bone Miner Res; 2001 Oct; 16(10):1829-36. PubMed ID: 11585347
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin is an effective countermeasure for spaceflight-induced bone loss in mice.
Lloyd SA; Morony SE; Ferguson VL; Simske SJ; Stodieck LS; Warmington KS; Livingston EW; Lacey DL; Kostenuik PJ; Bateman TA
Bone; 2015 Dec; 81():562-572. PubMed ID: 26318907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
